Can Öner

Dr. Can Öner

Family Medicine, Sağlık Bilimleri Üniversitesi, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2015 in Turkish Journal of Family Practice
Verified
Journal Article
Open access
PDF file
PHPınar Hamurcu
Pınar Hamurcu
CÖCan Öner
Can Öner
BTBerrin Telatar
Berrin Telatar
ŞYŞahin Yeşildağ
Şahin Yeşildağ
Giriş Günümüzün önemli halk sağlığı sorunlarından biri olan obezite, alınan ve harcanan enerji ara-sındaki dengesizlik sonucu yağ dokusunun artmasıdır. Obe

7 April 2015 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
SYSibel Yilmaz-Oner
Sibel Yilmaz-Oner
CÖCan Öner
Can Öner
FDFatih Mert Dogukan
Fatih Mert Dogukan
TMToklong Filam Moses
Toklong Filam Moses
KDKubra Demir
Kubra Demir
HDHaner Direskeneli
Haner Direskeneli

10 March 2015
Verified
Journal Article
Closed access
SYSibel Yilmaz-Oner
Sibel Yilmaz-Oner
CÖCan Öner
Can Öner
FDFatih Mert Dogukan
Fatih Mert Dogukan
TMToklong Filam Moses
Toklong Filam Moses
KDKubra Demir
Kubra Demir
HDHaner Direskeneli
Haner Direskeneli

30 June 2022 in Annals of Geriatric Medicine and Research
Verified
Journal Article
Open access
PDF file
BYBusra Yigit
Busra Yigit
CÖCan Öner
Can Öner
HCHuseyin Cetin
Huseyin Cetin
ESEngin Ersin Simsek
Engin Ersin Simsek
Background: Sarcopenia and cognitive disorders are frequently observed in older individuals. This study investigated the relationship between sarcopenia and cognitive function in this population.Methods: This cross-sectional study included 201 participants aged >65 years in Istanbul between July 1, 2020 and January 31, 2021. We screened all participants using the SARC-F (strength, assistance with walking, rising from a chair, climbing stairs, and falls) questionnaire to determine the risk of sarcopenia. Handgrip strength and skeletal muscle mass of participants at risk were measured to diagnose sarcopenia. Sarcopenia severity was evaluated using a 4-m walking speed test. We evaluated the cognitive status of participants using the Standardized Mini-Mental Test (SMMT) and the Standardized Mini-Mental Test for the Untrained (SMMT-E).Results: It was found that 10.9% (n=22) of participants was risky for sarcopenia and 6.0% (n=12) and 33.3% (n=4) had definite and severe sarcopenia, respectively. Examination of the association between cognitive impairment and SARC-F showed that 8.6% (n=14) of participants with normal cognitive function were at risk of sarcopenia compared to 20.5% (n=8) of participants with cognitive impairment (p=0.045). Evaluation of the relationship between cognitive function and sarcopenia status showed that 3.7% (n=6) of participants with normal cognitive function had sarcopenia compared to 15.4% (n=6) among participants with cognitive impairment (p=0.006).Conclusion: The rate of sarcopenia was significantly higher in older individuals with cognitive than those with normal cognitive functions.

1 August 2020 in Journal of the College of Physicians and Surgeons Pakistan
Verified
Journal Article
Closed access
YKYasin Kara
Yasin Kara
STSabah Tuzun
Sabah Tuzun
CÖCan Öner
Can Öner
ESEngin Ersin Simsek
Engin Ersin Simsek
To find the frequency of night eating syndrome (NES) in different obesity groups and to determine related factors. Descriptive cross-sectional study. Department of Family Medicine, Outpatient Clinics, University of Health Sciences, Kartal Dr. Lutfi Kirdar Training and Research Hospital from December 2018 to January 2019. Participants were divided into class I, class II, and class III obesity groups according to their BMI levels and administered a survey evaluating their sociodemographic features and a NES questionnaire. NES was detected in 92 (21.85%) of all participants; whereas, 28 participants (18.67%) of class I obesity group, 32 participants (22.70%) of class II obesity group and 32 participants (24.62%) of class III obesity group had NES (p=0.465). There was no significant difference between individuals with and without NES in terms of age, gender, marital status, income level, occupational status, presence of children, living-together subjects, cigarette consumption, BMI, waist-hip ratio, and waist-height ratio. However, within the class I obesity group, the likelihood of weight loss was significantly lower among participants with NES (p=0.026). There was no relationship between NES and the duration of obesity, dieting, and the number of main meals per day. However, the relationship between NES and the number of snacks per day was significant in class I and III obesity groups (p=0.040 and p=0.034, respectively). Conclusion: The frequency of NES was found to be high in all obesity groups with no significant difference across groups. Therefore, all obese patients should be evaluated in terms of NES, and nutritional recommendations should be provided in the treatment of obesity. Key Words: Morbid obesity, Night eating syndrome, Obesity.

1 January 2016 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
CÖCan Öner
Can Öner